Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Trial of Pemetrexed and Temozolomide in Treating Patients With Relapsed PCNSL

NCT01985451 is registered in ClinicalTrials.gov with Rongjie Tao as lead sponsor.

NCT NCT01985451
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01985451 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Trial of Pemetrexed and Temozolomide in Treating Patients With Relapsed PCNSL
Lead sponsor
Rongjie Tao
Phase
Phase 2
Overall status
Unknown status
Start date
March 31, 2013
Completion date
March 31, 2015
Enrollment
15 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

central nervous system tumors